Clinical Trial Update: Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating Tavo and pembrolizumab in advanced melanoma progressing on prior anti-PD-1 therapy (pembrolizumab or nivolumab).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iv Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Tavo

Snippet

Sponsor: OncoSec Medical Incorporated | Conditions: Stage III/IV Melanoma | Phase 2 | Status: UNKNOWN